Today, Remedy released its latest quarterly report for the period between October and December 2023. Despite the successful launch of Alan Wake 2, which was the fastest-selling game ever made by the studio even launching in a highly competitive release window, Q4 2023 marked a decrease in both revenue and profitability compared to 2022 due to significantly increased investments in the other game projects and to the impairment charge cost (€ -7.2 million) related to the reboot of the free-to-play Project Vanguard, from now on known as Kestrel. Still, Remedy revealed that Alan Wake 2 has now recouped most of […]
Read full article at https://wccftech.com/remedy-says-alan-wake-2-has-recouped-most-of-the-investment-studio-plans-more-regular-sequels-for-aw-control/
